In this video, Motley Fool health-care analyst David Williamson discusses what investors should look for in Eli Lilly's upcoming earnings report, and what the big pharma has in store for 2013.
Foolish Preview: Eli Lilly Earnings
What to expect for the big pharma's fourth quarter.
By Dave Williamson – Jan 28, 2013 at 8:06PM EST
Read Next
About the Author
The Motley Fool's Healthcare Analyst, I specialize in Pharma, Biotech, and how the ACA (Obamacare) is changing the business of healthcare in America. Follow me on Twitter for breaking stock news, policy thoughts, and misc musings...
Stocks Mentioned
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.